BREAKING THROUGH Trademark
Trademark Overview
On Monday, November 18, 2024, a trademark application was filed for BREAKING THROUGH with the United States Patent and Trademark Office. The USPTO has given the BREAKING THROUGH trademark a serial number of 98858307. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Sunday, May 24, 2026. This trademark is owned by Allergan Pharmaceuticals International Limited. The BREAKING THROUGH trademark is filed in the Advertising, Business and Retail Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Providing medical information, namely, information regarding medical conditions, treatments and products to patients and healthcare professionals; medical consultation, namely, providing advice to healthcare professionals regarding medical conditions and treatment
providing medical information, namely, consumer product information regarding medical products to patients and healthcare professionals
General Information
| Serial Number | 98858307 |
| Word Mark | BREAKING THROUGH |
| Filing Date | Monday, November 18, 2024 |
| Status | 748 - STATEMENT OF USE - TO EXAMINER |
| Status Date | Sunday, May 24, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 27, 2025 |
Trademark Statements
| Goods and Services | Providing medical information, namely, information regarding medical conditions, treatments and products to patients and healthcare professionals; medical consultation, namely, providing advice to healthcare professionals regarding medical conditions and treatment |
| Goods and Services | providing medical information, namely, consumer product information regarding medical products to patients and healthcare professionals |
Classification Information
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 18, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | Sunday, March 2, 2025 |
| First Use In Commerce Date | Sunday, March 2, 2025 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 18, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | Sunday, March 2, 2025 |
| First Use In Commerce Date | Sunday, March 2, 2025 |
Trademark Owner History
| Party Name | Allergan Pharmaceuticals International Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Dublin 17 D17E400
IE |
| Party Name | Allergan Pharmaceuticals International Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Dublin 17 D17E400
IE |
Trademark Events
| Event Date | Event Description |
| Monday, November 18, 2024 | NEW APPLICATION ENTERED |
| Monday, November 18, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, April 24, 2025 | ASSIGNED TO EXAMINER |
| Friday, April 25, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 21, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 27, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 27, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 22, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, January 21, 2026 | TEAS STATEMENT OF USE RECEIVED |
| Sunday, May 24, 2026 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, January 21, 2026 | USE AMENDMENT FILED |
| Sunday, May 24, 2026 | STATEMENT OF USE PROCESSING COMPLETE |
